Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Rankning i aktier #3556
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Aktiekurs
$3.28
Senast synkroniserad: 2026-07-31
Marknadsvärde
$5.10B
Förändring (1 dag)
0.00%
Förändring (1 år)
-49.70%
Land
TW
Handel Caliway Biopharmaceuticals Co. L (6919)

Kategori

Aktiekurshistorik för Caliway Biopharmaceuticals Co. L (6919)
Högsta slutkurs: $3.30 den 2026-07-01

Lägsta slutkurs: $0.20 den 2022-12-01
Aktiekurshistorik för Caliway Biopharmaceuticals Co. L från 2022 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -13.85%
2025 190.26%
2024 181.33%
2023 210.73%
2022 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$772.27 7.33%
CH